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The Fibromyalgia Survey Questionnaire (FSQ) was self-administered by a sample of 207
Italian individuals with obesity to screen for fibromyalgia (FM). We aimed to investigate the
inter-rater reliability and the agreement in the detection of FM symptomatology between
the self-administered FSQ and the clinical interview conducted by a rheumatologist.
All the patients were divided randomly into two groups (group A and group B): a
rheumatologist first interviewed patients of group A and after 48 h, the patients completed
the self-report FSQ. Patients of group B first completed the FSQ and 48 h later were
interviewed by a rheumatologist. The agreement between the measurements was good
with the Bland-Altman analysis showing low bias scores for the two subscales of the
FSQ. Results showed that 33% of the sample satisfied the criteria for a diagnosis of
fibromyalgia. The FSQ is a self-reporting measure that showed substantial reliability
providing fast screening for FM symptomatology.
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INTRODUCTION
Fibromyalgia (FM) is a syndrome with unclear etiopathogenesis, characterized by chronic
widespread pain, fatigue, sleep disturbances, and many other symptoms that significantly worsen
quality of life (Bazzichi et al., 2020). FM affects 2.31% of the European population, and 2.22% of the
Italian population (De Angelis et al., 2007; Cabo-Meseguer et al., 2017).
Several factors contribute to the intensity of its symptoms and to the resulting disability (Okifuji
and Turk, 2002; Wallace, 2006), among swhich, weight is one of the most significant (McKendall
and Haier, 1983; Khaodhiar et al., 2004). Evidence has shown that FM is closely associated with
overweight and obesity (Ursini et al., 2011). According to several studies, 62–73% of patients
with FM are overweight or obese (Yunus et al., 2002; Neumann et al., 2008; Okifuji and Hare,
2015). Specifically, a higher body mass index (BMI) seems to be positively correlated with disability
(Yunus et al., 2002; Creed, 2020), physical dysfunction, tender point count, pain sensitivity, and
sleep disturbances; but it is also negatively correlated with quality of life, tenderness threshold,
physical strength, and flexibility (Neumann et al., 2008; Okifuji et al., 2010). However, research on
individuals affected both by obesity and FM is still in its infancy.
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Early and precise diagnosis of FM is still difficult to obtain,
due to the complex poly-symptomatology, and the different
combination and severity of symptoms (Lawrence et al., 1998;
Salaffi et al., 2016). Several classification and diagnostic criteria
have been proposed, from the 1990 American College of
Rheumatology (ACR) classification criteria to the 2010 ACR
criteria, which consisted of three benchmarks:
Criterion 1: Widespread Pain Index (WPI) ≥ 7 and Symptom
Severity Score (SSS) ≥5 or WPI 3–6 and SSS ≥9;
Criterion 2: Symptoms have been present at a similar level for
at least 3 months;
Criterion 3: The patient does not have a disorder that would
otherwise explain the pain.
TheWPI includes 19 non-articular pain sites; meanwhile, the SSS
measures the severity of three major symptoms (fatigue, trouble
thinking or remembering, waking unrefreshed), and the severity
of the somatic symptoms in general, rated by the physician.While
for this classification, the SSS score required physician evaluation,
a further change in 2011 removed the physician assessment of
the extent of somatic symptoms and replaced it by a summary
score of three self-reported symptoms, making it easier to use.
This modification enabled researchers to use these criteria in
epidemiological and clinical studies without the requirement for
an examiner.
Lastly, after the 2016 revision, fibromyalgia may be diagnosed
when all of the following criteria are met: (1) WPI ≥ 7/19 pain
sites and SSS ≥ 5/12 or WPI between > 3–6/19 and SSS > 9/12;
(2) symptoms have been present at a similar level for at least 3
months; (3) the patient does not have another disorder that would
otherwise sufficiently explain the pain; and (4) generalized pain,
defined as pain in at least four of five regions, is present (Wolfe
et al., 2016).
Beyond the set of criteria used, the diagnosis of FM remains
difficult; it requires differential diagnoses with several medical
conditions, and the diagnostic delay can have a significant impact
on the quality of life and emotional state of patients, as well as on
health care and social costs (Di Franco et al., 2011). One of the
most used tools for the evaluation of fibromyalgia symptoms is
the Fibromyalgia Impact Questionnaire-Revised, FIQR (Bennett
et al., 2009), which accurately measures the level of disability
associated with the disease, especially in terms of function, global
impact, and symptoms. This questionnaire is not suitable for the
screening of fibromyalgia symptoms, according to the 2010/2011
ACR criteria.
Recently, the Fibromyalgia Screening Questionnaire (FSQ)
has been proposed for this purpose to assess ACR conditions 1
and 2 on the two subscales: the WPI and the SSS (Häuser et al.,
2012).
Our research question focused on evaluating whether the
ability of the FSQ to detect fibromyalgia was equal to that of
a clinical interview conducted by a rheumatologist. The clinical
interview is based on the three criteria from 2010 reported above,
for which the presence of an examiner is required; whereas the
FSQ is based on the 2011 modification of the ACR criteria,
assessing criteria 1 and 2, through the WPI and SSS scales
(Häuser et al., 2012), and excluding criterion three, which can
only be evaluated by a rheumatologist.
The objective of our study was to calculate the inter-rater
reliability and the agreement between the Italian translation of
the self-administered FSQ and the clinical interview conducted
by a rheumatologist (see Wolfe et al., 2010), in detecting the
symptomatology of FM in a sample of Italian patients with
obesity and generalized pain.
MATERIALS AND METHODS
Participants and Procedures
Participants of the study were recruited from May 2014 to
September 2014 at the Istituto Auxologico Italiano –Istituto di
Ricovero e Cura a Carattere Scientifico (Piancavallo–Italy), a
clinic specializing in the rehabilitation of obesity and physical
therapy. Consecutive patients were asked to take part in the study
and give their informed written consent to the study, which had
been approved by the Institutional Ethics Committee.
Demographic data (age, gender, educational level) were
assessed using a self-report questionnaire. Two-hundred and
twenty-five obese patients were recruited: 12 did not give their
consent to the study and six patients were excluded from the
analyses because of a high number of missing items; the final
sample consisted of 207 subjects.
Materials
The FSQ had been forward and back translated to ensure the
semantic equivalence of the Italian and the English version
by four rheumatologists, fluent in English, and experts in
fibromyalgia. The clinical interview was conducted according
to the 2010 ACR criteria (Wolfe et al., 2010). All the patients
were divided randomly into two groups: a rheumatologist first
interviewed group A and after 48 h, the patients completed the
FSQ. Patients of group B first completed the FSQ and 48 h later
were interviewed by a rheumatologist.
The questionnaire is divided in two subscales: the WPI is
obtained by summing the body areas (out of 19 possible sites)
in which the patient indicates they experienced pain during the
preceding week, i.e., it can range from 0 to 19. The SSS consists
of two parts:
Part 1: the patient grades the severity over the last week
of three somatic symptoms (waking unrefreshed, disturbed
cognition, and fatigue) on a scale of 0–3, resulting in a maximum
score of 9;
Part 2: the patient grades the severity of the following three
symptoms on a 4-point scale (0 = absent, 1 = slight, 2 =
moderate, or 3 = severe), occurring during the previous 6
months: headaches, pain, or cramps in the lower abdomen and
depression (a 0–12 total score).
Furthermore, a poly-symptomatic distress (PSD) scale can be also
calculated by the sum of the two component scores, WPI and SSS
(Wolfe et al., 2016).
Statistical Analysis
All statistical analyses were performed using the Statistical
Package for Social Science for Mac (SPSS-24, IBM SPSS Statistics
for Macintosh, IBM Corp., Armonk, NY, USA).
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FIGURE 1 | Bland-Altman 95% limits of agreement plot for PSD.
Descriptive statistics were used to describe the socio-
demographic and clinical data. Internal consistency of the total
scales and relative subscales was assessed by Cronbach’s α; values
of 0.7 and higher were considered desirable (Nunnally and
Bernstein, 1994).
Cohen’s kappa statistic and intraclass correlation coefficient
(ICC) were used to measure agreement between the two different
tools, using a two-way mixed-effect model based on single
ratings, for criteria 1 and 2. Mean estimations along with
95% confidence intervals (CI) were reported for each ICC.
Furthermore, to measure continuous variable agreement (PSD,
WPI, and SSS), we used Bland-Altman analysis (Bland and
Altman, 1986): a scatter plot was constructed in which the
differences between questionnaire and interview measurements
were plotted on the y-axis and the average of the measures of
two approaches on the x-axis. The mean difference in values
obtained with the two approaches is the bias, represented by a
central horizontal line on the scatter plot. Above and below the
horizontal line, the 95% limits of agreement (LOA), expressed
as the mean difference ±1.96, are represented: the smaller the
range between these two limits, the better the agreement. The
differences between the values were tested with a Student’s t-test.
A level of significance of p < 0.05 was considered.
RESULTS
Most participants were female (165 vs. 42 males; mean age: 63.2
± 12.4). All participants had a diagnosis of obesity, with a level of
BMI≥ 30 (mean± SD: 40.54± 6.45). More than half the patients
(59%) had achieved a basic education and only 20 subjects (10%)
had a tertiary education level.
Cronbach’s alpha of the SSS was 0.710. Cohen’s κ was run to
determine if there was an agreement between the FSQ and the
clinical interview conducted by a rheumatologist, in satisfying
the criteria 1 and 2 for FM (see the above mentioned 2011
ACR criteria). Sixty-nine (33%) subjects were found positive
by both the FSQ and interview vs. 103 patients that did not
satisfy the criteria. There was good agreement between the two
measurements, κ = 0.653 (95% CI, 0.55–0.757), with a p <
0.0005, index of a substantial strength of agreement (Altman,
1999). A minor discordant result was found for 16 patients, who
were positive for the interview but not for the FSQmeasurement.
A high degree of reliability on criterion 1 was also underlined
by the interclass correlation. For the PSD scale, the average ICC
measure was 0.899 with a 95% CI from 0.867 to 0.923, indicating
good reliability (Koo and Li, 2016). Similarly, the average ICC
measure for WPI was 0.888 (0.853–0.915) and for SSS was 0.851
(95% CI, 0.804 to 0.887).
A low bias score between the two assessments was found:
regarding PSD, a bias of 0.43 (p = 0.118) was found with
the Bland-Altman 95% limits of agreement of −0.97 and 0.11
(Figure 1). Specifically, PSD detected by the FSQwas 12.5± 6.61,
whereas the mean score at the interview was 13± 6.5.WPI scores
were 7.41± 4.22 by the interview, slightly greater than by patient
measures (7.26 ± 4.23) with a difference of 0.134 (p = 0.472).
Similar values were found for the SSS, with a bias of 0.030 (p =
0.062): mean scores found by the FSQ were 5.29 ± 3.22 vs. 5.59
± 4.22 by the interview.
DISCUSSION
The aim of this study was to evaluate the agreement and inter-
rater reliability between the self-administered FSQ and a clinical
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interview conducted by a rheumatologist, for the detection of
fibromyalgia symptoms. Since the results suggest that there is
a good agreement and good inter-rater reliability between the
two instruments, we can recommend the use of FSQ as a valid
screening tool.
To date, there is no consensus on an ideal measurement to
assess the severity of symptoms in FM or to monitor patients for
symptoms, outcomes, or changes. Although criticized because it
does not fully address all the aspects of FM, FIQR is a specific
questionnaire for FM and addresses several and specified areas
for this condition (Rivera and González, 2004; Bennett et al.,
2009); however, it may not be sufficiently sensitive to changes.
FM diagnosis can be complex and challenging, and usually,
its diagnosis requires a lot of time. Most patients are diagnosed
on average 2.3 years after first presenting FM complaints
to a physician (Marcus et al., 2013). The requirement for a
physician’s examination is a major limitation in understanding
FM prevalence and characteristics. Therefore, the FSQ may be a
useful tool to assist the physician’s diagnosis and to accelerate the
diagnostic process.
Indeed, a screening tool is necessary for use in settings
where the presence of an interviewer would be difficult and can
provide meaningful information on the overall status of FM
symptomatology (Shir et al., 2012). Our results, similar to those
of Wolfe et al. (2016), underlined that the FSQ appears to be an
appropriate tool for the screening purposes of symptomatology.
While the results of the questionnaire and the interview
appear to be comparable to the scores on the SSS and WPI
scales, subtle differences were found in the satisfaction with
the diagnosis. We must, however, remember that the clinical
interview is based on the three criteria from 2010, in which the
presence of an examiner is required; whereas the FSQ is based on
the 2011 modification of the ACR criteria, assessing only criteria
1 and 2.
Patients affected by FM often undergo unnecessary medical
examinations before their diagnosis is finally confirmed, and
ineffective and incongruous treatmentsmay be administered, due
to delay and misdiagnosis.
We found an overall good agreement: specifically, for the PSD
and the SSS scores, we found similar values of bias, while a
significantly lower bias was found for the WPI scores, compared
to Wolfe’s (2016) results. Also, concerning the composition
of our sample, we found that approximately a third of the
patients satisfied the criteria for FM, in line with a previous
study conducted on obese patients that reported a prevalence
rate of 27.7% (Arreghini et al., 2014). Individuals affected by
fibromyalgia and/or obesity may lie on the same syndrome
continuum: it is known that a high body mass represents a risk
factor for the development of chronic widespread pain (Creed,
2020); therefore, a vicious circle in the behavior of those suffering
from obesity and fibromyalgia could be hypothesized.
Given the poor generalizability of our work, performed on a
relatively small sample of patients with obesity, further validation
studies in the Italian language and on a larger patient population
are needed.
In conclusion, a self-reporting measure like the FSQ could
provide a time-efficient method for the initial identification
of patients with high pain sensitivity. Early diagnosis allows
for the initiation of non-pharmacological approaches, such as
psychotherapy or physical treatment, and could also reduce
national healthcare costs.
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